Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials Academic Article Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Coronary Artery Disease
  • Drug-Eluting Stents
  • Heart Transplantation

abstract

  • Urgent coronary artery bypass grafting operations can be performed without an incremental increase in major hemorrhagic risk among patients on abciximab therapy.

authors

publication date

  • September 6, 2000

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0003-4975(00)01343-6

PubMed ID

  • 10969673

Additional Document Info

start page

  • 516

end page

  • 26

volume

  • 70

number

  • 2